Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,181 to 1,200 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01CA095175 | Analysis of BRCA1 recombination functions | 1 | 2021 |
| R01CA166480 | MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer | 1 | 2021 |
| R01CA204002 | Inherent tropism and/or immune modulation in melanoma brain metastasis | 1 | 2021 |
| R01CA204127 | Functions of human RAD51 and its paralogs during DNA interstrand crosslink repair | 1 | 2021 |
| R01CA204806 | Consequences and mechanism of aberrant splicing in African American prostate cancer disparities | 1 | 2021 |
| R01CA205426 | Elucidating genetics of response to immune checkpoint blockade in lung cancer | 1 | 2021 |
| R01CA206890 | Imaging tumor associated macrophage (TAM) function | 1 | 2021 |
| R01CA207935 | Effect of the aged microenvironment on tumor dormancy | 1 | 2021 |
| R01CA208213 | Inhibition of brain metastasis by blocking MAPK12 driver kinase functions | 1 | 2021 |
| R01CA211073 | Role of MIF in myeloma bone homing and drug response | 1 | 2021 |
| R01CA211861 | The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker | 1 | 2021 |
| R01CA214811 | Targeting macrophages to sensitize myeloma to immune checkpoint blockade | 1 | 2021 |
| R01CA218356 | A blood test to identify prostate cancer patients at risk for visceral metastasis | 1 | 2021 |
| R01CA229851 | Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma | 1 | 2021 |
| R01DC015788 | Modeling Genetic Inner Ear Disorders with Human Pluripotent Stem Cells | 1 | 2021 |
| R01DE025884 | The role of TGFbeta in development and function of salivary gland innate lymphoid cells | 1 | 2021 |
| R01DK112296 | The impact of HIV-1 infection and its treatment on gastrointestinal B cells | 1 | 2021 |
| R01EB025207 | Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies | 1 | 2021 |
| R01ES001332 | Reproductive and Developmental Toxicity of Dioxin | 1 | 2021 |
| R01GM103899 | Structural Insights into TRPV Channel Gating | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=60